We take a look at directors buying and selling shares in their own company in our weekly column.
- Non Exec Chair buys shares in GSK
- Anglo American non exec directors acquire shares through in ‘lieu of fees’ scheme
- Chief Executive buys shares in Greggs
Here’s why Director Dealings can play an important role in stock-picking
Non Exec Chair buys shares in GSK
GSK [LON:GSK] Non Executive Chair, Sir Johnathan Simmons has purchased 6,000 shares in the company at 1,439.79p for a total consideration of £86,387. In addition, Julie Brown, Chief Financial Officer purchased 22,500 shares at 1429.13p for a total consideration of £321,554. The purchases came on the back of news of a settlement over GSK’s Zantac drug. The terms of the settlement were confidential but the FTSE 100 Pharma stock has not admitted any liability. The settlement was made to “avoid distraction related to protracted litigation” and end the uncertainty in the markets over the case.
At the time of writing, GSK shares were trading at 1406p, down 3% for the year to date and -21% over the last 12 months.
Anglo American non exec directors acquire shares through in ‘lieu of fees’ scheme
Anglo American [LON:AAL] Non Executive Directors Stuart Chambers and Nonkululeko Nyembezi acquired 723 and 299 shares respectively in the company this week through a ‘Shares in lieu of fees’ scheme. The value of the acquisitions amounted to £16,462 for Stuart Chambers and £6,808 for Nonkululeko Nyembezi. The FTSE 100 Mining stock has announced changes to its leadership team, effective from 1st July designed to lead its next phase of value delivery.
Ongoing China economic growth concerns and a lack of detail on future stimulus for the country have weighed on recent sentiment for Anglo American shares which were trading at 2,270p today, down 30% for the year to date and -28% over the last 12 months.
- Three Quick Facts: Anglo American, Pearson, Senior
- Can GSK and AstraZeneca stay competitive in tomorrow’s pharma market?
- Three Quick Facts: Greggs, Ashtead, Intertek
Chief Executive buys shares in Greggs
Greggs [LON:GRG] Chief Executive, Roisin Currie on 23rd June purchased 3,077 shares at 2,632p for a total consideration of £80,986. On the same day, Finance Director Richard Hutton bought 2,514 shares at the same price for a total cost of £66,168. Last month, the FTSE 250 Bakery chain published a trading update covering the first 19 weeks of the year. Like for like sales growth were in excess of 17% while new store sales continued apace. Although the company continues to see input cost inflation as a challenge, the fact that disposable incomes are likely to remain under pressure is seen as reinforcing the company’s value proposition.
Greggs shares were trading at 2,570p today, an increase of 7% this year and up 34% over the last 12 months.
